MAYNE Pharma Group will be
the recipient of up to $4 million
in government funding after a
successful application under the
Next Generation Manufacturing
Investment Program.
The money will help support
the installation of an $11 million
large scale state-of-the-art fluid
bed spray coater at the company’s
manufacturing facility in Salisbury,
South Australia.
CEO Scott Richards said the
expansion of Mayne’s modifiedrelease
manufacturing capability
would help handle expected growth
in current products as well as the
commercialisation of other items
currently in the pipeline.
He said Mayne has directed more
than 80% of its Australian-based
research and development spend
to the development of advanced
oral drug delivery formulations.
“Today more than half of global
pharmaceutical prescription
revenues come from dose forms
that require more than simple
immediate-release tablets,” he said.The above article was sent to subscribers in Pharmacy Daily's issue from 05 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Aug 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.